Differential Diagnosis of Suspected Multiple Sclerosis in Pediatric and Late-Onset Populations A Review

被引:0
|
作者
Hua, Le H. [1 ]
Solomon, Andrew J. [2 ]
Tenembaum, Silvia [3 ]
Scalfari, Antonio [4 ]
Rovira, Alex [5 ]
Rostasy, Kevin [6 ]
Newsome, Scott D. [7 ]
Marrie, Ruth Ann [8 ]
Magyari, Melinda [9 ]
Kantarci, Orhun [10 ]
Hemmer, Bernhard [11 ,12 ]
Hemingway, Cheryl [13 ,14 ]
Harnegie, Mary Pat [15 ]
Graves, Jennifer S. [16 ]
Cohen, Jeffrey A. [17 ]
Bove, Riley [18 ]
Banwell, Brenda [19 ]
Corboy, John R. [20 ]
Waubant, Emmanuelle [18 ]
机构
[1] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 W Bonneville Ave, Las Vegas, NV 89106 USA
[2] Univ Vermont, Larner Coll Med, Burlington, VT USA
[3] Natl Pediat Hosp Dr J P Garrahan, Dept Neurol, Buenos Aires, Argentina
[4] Imperial Coll London, Charing Cross Hosp, Ctr Neurosci, Dept Med, London, England
[5] Hosp Univ Vall dHebron, Barcelona, Spain
[6] Univ Witten Herdecke, Childrens Hosp Datteln, Witten, Germany
[7] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[8] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Winnipeg, MB, Canada
[9] Copenhagen Univ Hosp, Rigshosp, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark
[10] Mayo Clin, Dept Neurol, Rochester, MN USA
[11] Tech Univ Munich, Dept Neurol, Munich, Germany
[12] Munich Cluster Syst Neurol, Munich, Germany
[13] Great Ormond St Childrens Hosp, Paediat Neurol, London, England
[14] UCL, Inst Neurol, London, England
[15] Cleveland Clin, Cleveland Clin Lib, Cleveland, OH USA
[16] Univ Calif San Diego, Dept Neurosci, San Diego, CA USA
[17] Cleveland Clin, Neurol Inst, Mellen Ctr MS Treatment & Res, Cleveland, OH USA
[18] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA USA
[19] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA USA
[20] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO, South Africa
关键词
GADOLINIUM-ENHANCEMENT; NEUROMYELITIS-OPTICA; AGE; BRAIN; MS; CHILDREN; SEX; CONSENSUS; SPECTRUM; LESIONS;
D O I
10.1001/jamaneurol.2024.3062
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Importance While the typical onset of multiple sclerosis (MS) occurs in early adulthood, 2% to 10% of cases initially present prior to age 18 years, and approximately 5% after age 50 years. Guidance on approaches to differential diagnosis in suspected MS specific to these 2 age groups is needed. Observations There are unique biological factors in children younger than 18 years and in adults older than age 50 years compared to typical adult-onset MS. These biological differences, particularly immunological and hormonal, may influence the clinical presentation of MS, resilience to neuronal injury, and differential diagnosis. While mimics of MS at the typical age at onset have been described, a comprehensive approach focused on the younger and older ends of the age spectrum has not been previously published. Conclusions and Relevance An international committee of MS experts in pediatric and adult MS was formed to provide consensus guidance on diagnostic approaches and key clinical and paraclinical red flags for non-MS diagnosis in children and older adults.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Radiological features of late-onset multiple sclerosis: A systematic review and meta-analysis
    Nasiri, Ehsan
    Sarkesh, Aila
    Sorkhabi, Amin Daei
    Naseri, Amirreza
    Daneshvar, Sara
    Moghadasi, Abdorreza Naser
    Talebi, Mahnaz
    [J]. JOURNAL OF NEURORADIOLOGY, 2023, 50 (06) : 571 - 580
  • [42] MULTIPLE-SCLEROSIS WITH VERY LATE-ONSET - REPORT OF 6 CASES AND REVIEW OF THE LITERATURE
    AZZIMONDI, G
    STRACCIARI, A
    RINALDI, R
    DALESSANDRO, R
    PAZZAGLIA, P
    [J]. EUROPEAN NEUROLOGY, 1994, 34 (06) : 332 - 336
  • [43] LATE-ONSET MULTIPLE SCLEROSIS IN SOUTH-EAST WALES
    Harding, Katharine
    Griffiths, Megan
    Wardle, Mark
    Tomassini, Valentina
    Pickersgill, Trevor
    Robertson, Neil
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [44] Differential diagnosis of suspected multiple sclerosis: a consensus approach
    Miller, D. H.
    Weinshenker, B. G.
    Filippi, M.
    Banwell, B. L.
    Cohen, J. A.
    Freedman, M. S.
    Galetta, S. L.
    Hutchinson, M.
    Johnson, R. T.
    Kappos, L.
    Kira, J.
    Lublin, F. D.
    McFarland, H. F.
    Montalban, X.
    Panitch, H.
    Richert, J. R.
    Reingold, S. C.
    Polman, C. H.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (09) : 1157 - 1174
  • [45] Late-Onset Adrenoleukodystrophy Mimicking Primary Progressive Multiple Sclerosis
    Schabas, Alice
    Sayao, Ana-Luiza
    [J]. NEUROLOGY, 2016, 86
  • [46] The clinical features of late-onset multiple sclerosis in Greek patients
    Andreadou, E.
    Katirtzoglou, E.
    Evangelopoulos, M. E.
    Koutsis, G.
    Oikonomou, E.
    Dimitriou, A.
    Kilidireas, K.
    Vassilopoulos, D.
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 : S77 - S77
  • [47] Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis
    Cohen, Bruce A.
    [J]. NEUROLOGY, 2019, 92 (09) : 435 - 436
  • [48] The Aging Face of Multiple Sclerosis: A Comparative Analysis of Young-Onset versus Late-Onset Multiple Sclerosis
    Wruble, Mattia
    Goldman, Myla
    [J]. ANNALS OF NEUROLOGY, 2019, 86 : S95 - S96
  • [49] Cognitive outcomes in late-onset versus adult-onset Multiple Sclerosis
    Oliveira, Ana Ines
    Monteiro, Isabel Rovisco
    Alferes, Alexandre Roldao
    Santos, Irina
    Machado, Rita
    Correia, Ines
    Macario, Carmo
    Nunes, Carla Cecilia
    Batista, Sonia
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 90
  • [50] Reduced oligodendrocyte populations may underlie less effective remyelination in patients with late-onset multiple sclerosis
    Stephan, S.
    Stork, L.
    Brueck, W.
    Stadelmann, C.
    Metz, I.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 21 - 22